• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 4
  • 1
  • 1
  • 1
  • Tagged with
  • 8
  • 8
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Avaliação da produção de toxina tetânica por \"Clostridium tetani\" cultivado por processos fermentativos descontínuo e descontínuo alimentado / Evaluation of the tetanus toxin for \"Clostridium tetani\" cultivated by batch fermentative and fed-batch process

Fernando Fratelli 04 May 2007 (has links)
A toxina tetânica é uma proteína sintetizada pelo bacilo Clostridium tetani que após destoxificação através da ação do formol, continua apresentando propriedades antigênicas e imunogênicas, obtendo a denominação toxóide tetânico. A síntese dessa proteína ocorre quando esse bacilo encontra-se na sua forma vegetativa e em meio de cultura específico relativamente complexo contendo glicose e peptonas. O efeito simultâneo de diferentes níveis de glicose (Go) e N-Z Case TT® (NZo) como fontes de carbono e nitrogênio, respectivamente, na produção de toxina tetânica foi investigada nesta primeira parte do trabalho em cultivo estático por meio de planejamento fatorial em estrela com cinco níveis e avaliado por metodologia de superfície de resposta, com a finalidade de otimização do processo. O valor mais alto de toxina tetânica encontrado, correspondente a Go = 9,7 g/L e NZo = 43,5 g/L, foi 79% maior que aqueles obtidos em condições padrões de cultivo (Go = 8,0 g/L e NZo = 25,0 g/L). Também foram realizados cultivos de C. tetani utilizando o processo descontínuo alimentado com diferentes protocolos para a correção da concentração de glicose no meio de cultivo ao longo do tempo em diferentes concentrações iniciais de N-Z Case TT®. Dois grupos de ensaios foram executados: a) experimentos realizados com a correção da concentração de glicose para 3,0 g/L nos instantes 16, 56 e 88 h e b) experimentos com correção inicial da concentração de glicose para 3,0 g/L e após esta cair para 1-1,5 g/L. O primeiro protocolo de correção da concentração de glicose e NZo = 50,0 g/L foram as melhores condições para obtenção de toxina tetânica. Nestas condições, o título de toxina tetânica foi 300% maior que aqueles obtidos em cultivos padrão. / The tetanus toxin is a neurotoxin synthesized by the bacillus Clostridium tetani that, after detoxification with formaldehyde, still exhibits antigenic and immunologic properties, hence its denomination of tetanus toxoid. Such a neurotoxin is produced by cultivations of the microorganism in vegetative form on a relatively complex specific medium containing glucose and peptone. The simultaneous effects of the starting levels of glucose (Go) and N-Z Case TT® (NZo) as carbon and nitrogen sources, respectively, on the production of tetanus toxin, have been investigated in this work in static cultivations by means of a five-levels star-shaped experimental design and evaluated by Response Surface Methodology (RSM) for optimization purposes. The highest final average yield of tetanus toxin, achieved at Go = 9.7 g/L and NZo = 43.5 g/L, was 79% higher than that obtained with standard cultivations (Go = 8.0 g/L and NZo = 25.0 g/L). Also, there were carried out cultivations of C. tetani using fed-batch process at different protocols to correct the glucose concentration in the cultivation medium along the time at different initial N-Z Case TT® concentrations (NZo). Two series of runs were performed: a) experiments with the correction of the glucose concentration to 3.0 g/L in the times 16, 56 and 88 hours and b) experiments with initial correction of the glucose concentration to 3.0 g/L and after it to drop to 1-1,5 g/L. The former protocol to correct the glucose concentration and NZo = 50.0 g/L were the best condition to obtain tetanus toxin. In these conditions, the yield of tetanus toxin was 300% higher than that obtained with standard cultivations.
2

Avaliação da produção de toxina tetânica por \"Clostridium tetani\" cultivado por processos fermentativos descontínuo e descontínuo alimentado / Evaluation of the tetanus toxin for \"Clostridium tetani\" cultivated by batch fermentative and fed-batch process

Fratelli, Fernando 04 May 2007 (has links)
A toxina tetânica é uma proteína sintetizada pelo bacilo Clostridium tetani que após destoxificação através da ação do formol, continua apresentando propriedades antigênicas e imunogênicas, obtendo a denominação toxóide tetânico. A síntese dessa proteína ocorre quando esse bacilo encontra-se na sua forma vegetativa e em meio de cultura específico relativamente complexo contendo glicose e peptonas. O efeito simultâneo de diferentes níveis de glicose (Go) e N-Z Case TT® (NZo) como fontes de carbono e nitrogênio, respectivamente, na produção de toxina tetânica foi investigada nesta primeira parte do trabalho em cultivo estático por meio de planejamento fatorial em estrela com cinco níveis e avaliado por metodologia de superfície de resposta, com a finalidade de otimização do processo. O valor mais alto de toxina tetânica encontrado, correspondente a Go = 9,7 g/L e NZo = 43,5 g/L, foi 79% maior que aqueles obtidos em condições padrões de cultivo (Go = 8,0 g/L e NZo = 25,0 g/L). Também foram realizados cultivos de C. tetani utilizando o processo descontínuo alimentado com diferentes protocolos para a correção da concentração de glicose no meio de cultivo ao longo do tempo em diferentes concentrações iniciais de N-Z Case TT®. Dois grupos de ensaios foram executados: a) experimentos realizados com a correção da concentração de glicose para 3,0 g/L nos instantes 16, 56 e 88 h e b) experimentos com correção inicial da concentração de glicose para 3,0 g/L e após esta cair para 1-1,5 g/L. O primeiro protocolo de correção da concentração de glicose e NZo = 50,0 g/L foram as melhores condições para obtenção de toxina tetânica. Nestas condições, o título de toxina tetânica foi 300% maior que aqueles obtidos em cultivos padrão. / The tetanus toxin is a neurotoxin synthesized by the bacillus Clostridium tetani that, after detoxification with formaldehyde, still exhibits antigenic and immunologic properties, hence its denomination of tetanus toxoid. Such a neurotoxin is produced by cultivations of the microorganism in vegetative form on a relatively complex specific medium containing glucose and peptone. The simultaneous effects of the starting levels of glucose (Go) and N-Z Case TT® (NZo) as carbon and nitrogen sources, respectively, on the production of tetanus toxin, have been investigated in this work in static cultivations by means of a five-levels star-shaped experimental design and evaluated by Response Surface Methodology (RSM) for optimization purposes. The highest final average yield of tetanus toxin, achieved at Go = 9.7 g/L and NZo = 43.5 g/L, was 79% higher than that obtained with standard cultivations (Go = 8.0 g/L and NZo = 25.0 g/L). Also, there were carried out cultivations of C. tetani using fed-batch process at different protocols to correct the glucose concentration in the cultivation medium along the time at different initial N-Z Case TT® concentrations (NZo). Two series of runs were performed: a) experiments with the correction of the glucose concentration to 3.0 g/L in the times 16, 56 and 88 hours and b) experiments with initial correction of the glucose concentration to 3.0 g/L and after it to drop to 1-1,5 g/L. The former protocol to correct the glucose concentration and NZo = 50.0 g/L were the best condition to obtain tetanus toxin. In these conditions, the yield of tetanus toxin was 300% higher than that obtained with standard cultivations.
3

Exosomes neuronaux : rôle dans le passage intercellulaire de protéines et d'ARN / neuronal exosomes : role in the intercellular transfer of proteins and RNAs

Chivet, Mathilde 20 February 2013 (has links)
Les exosomes sont des vésicules d'origine endocytaire sécrétées par les cellules dans leur environnement après fusion des endosomes multivésiculés avec la membrane plasmique. Ils représentent un nouveau moyen de communication cellulaire par le transfert intercellulaire de protéines, de lipides et d'ARN. Dans le laboratoire, nous nous intéressons aux rôles que pourraient jouer les exosomes neuronaux dans le système nerveux central. Nous avons montré que les neurones matures sécrètent des exosomes. Nous avons mis en évidence que cette sécrétion est directement reliée à l'activité synaptique glutamatergique et à une entrée de Ca2+. Nous avons également découvert que la partie C-terminale de la chaîne lourde de la toxine du tétanos peut être sécrétée par voie exosomale. Nous avons observé que les exosomes la contenant sont repris par des neurones en culture. Un tel cargo semble d'ailleurs influencer le devenir des exosomes. De plus, pour étudier la recapture des exosomes, nous avons utilisé des exosomes de cellules N2a exprimant la tétraspanine CD63 fusionnée à la GFP. En incubant des neurones d'hippocampe avec des exosomes GFP-CD63, nous sommes parvenus à démontrer qu'ils étaient endocytés par les neurones receveurs. Cependant, bien que les exosomes semblent avoir été internalisés, nos résultats suggèrent que leur trafic serait indépendant de la voie endocytaire classique. Enfin, nous nous sommes intéressé au contenu en ARN des exosomes de N2a et de neurones. Nous avons démontré qu'ils contenaient majoritairement des ARN courts (≤ 200 nucléotides) parmi lesquels, les microARN 132 et 138. Les microARN sont de puissants régulateurs de l'expression génique. Leur transfert, via les exosomes, représenterait une nouvelle voie de régulation très fine et avec un impact conséquent sur le fonctionnement du système nerveux. Les exosomes neuronaux pourraient donc jouer un rôle dans la physiologie normale de la synapse, en permettant l'échange d'ARN et de récepteurs aux neurotransmetteurs entre neurones. Ils pourraient également être impliqués dans la propagation de protéines pathogènes comme la toxine du tétanos et la propagation de certaines maladies neurodégénératives comme Alzheimer et Creutzfeldt-Jacob. L'ensemble de nos résultats suggère que les exosomes joueraient un rôle-clé dans le système nerveux central, de par leur implication dans des processus physiologiques et pathologiques. / Exosomes are vesicles of endocytic origin released by cells into their environment on fusion of multivesicular endosomes with the plasma membrane. They represent a novel mechanism of cell communication by intercellular transfer of proteins, lipids and RNAs. In our laboratory, we are interested in the roles neuronal exosomes could play in the central nervous system. We first showed that mature neurons secrete exosomes and that this is regulated by synaptic glutamatergic activity and by Ca2+ influx. We next demonstrated that the C-terminal part of the tetanus toxin heavy chain can be released in association with neuronal exosomes which can then be taken up by other neurons. Moreover, such a cargo seems to influence the actual fate of the exosome. In order to further examine exosome reuptake, we used exosomes from N2a cells expressing the tetraspanin CD63 fused to the green fluorescent protein, GFP. By incubating cultured hippocampal neurons with GFP-CD63 exosomes, we succeeded in proving that they were found inside the recipient neurons. However, although exosomes are internalized, our results suggest that their traffic is independent of the classical endosomal pathway. We also studied the RNAs contained in the N2a and neuronal exosomes. These were mainly short RNAs (≤ 200 nucleotides) including microRNAs 132 and 138. MicroRNAs are key regulators of gene expression. Their transfer by exosomes could represent a new way for fine regulation with a potentially powerful impact on the nervous system. Neuronal exosomes could play a crucial role in the normal physiology of synapses, by allowing the exchange of RNAs and neurotransmitter receptors between neurons. They could also propagate pathogenic proteins such as tetanus toxin and be involved in neurodegenerative disorders such as Alzheimer's and Creutzfeldt-Jacob's diseases. Altogether, our results pave the way towards the demonstration that exosomes play an important part in the functioning of the central nervous system via their involvement in physiological and pathological processes.
4

Morfologické zmeny hipokampu v tetanotoxínovom modeli temporálnej epilepsie / Morphological changes of the hippocampus in tetanus toxin model of temporal lobe epilepsy

Demeterová, Ľubica January 2015 (has links)
Temporal lobe epilepsy is the most common form of epilepsy and hippocampal sclerosis represents the main underlying structural abnormity. Approximately 20% of TLE cases are non- lesional due to absence of any obvious epileptogenic lesion and tetanus toxin model is traditionally considered as a model of non-lesional temporal lobe epilepsy. The main aim of this study was to evaluate the presence of the cell damage and to determine its spatiotemporal profile. Tetanus toxin was stereotaxically injected into CA3 subregion of dorsal hippocampus in adult male Wistar rats. Brain tissue was extracted 4, 8 and 16 days following the surgery. Postfixed brains were sectioned to 50 µm slices and labeled using Nissl's and FluoroJade B staining (FJB). Hippocampal sclerosis was present only in animals from D16 group, however, it was localized mainly in contralateral CA1 area. Additional finding was decreased Nissl's staining in contralateral hippocampus which corresponded with the presence of FJB positive neurons. In animals from group D8, we have identified presence of FJB positive neurons predominantly in ipsilateral hippocampus. In D4 animals, cellular degeneration was absent. To examine the non- lesional nature of tetanus toxin model, we have performed blind study, when Nissl's staining were reviewed...
5

Obtenção de anticorpos monoclonais humanos antitetânicos. / Anti-tetanus human monoclonal antibodies.

Aliprandini, Eduardo 12 August 2015 (has links)
Anticorpos monoclonais (AcMos) para uso terapêutico correspondem a uma área importante na indústria de biofármacos, em especial os AcMos humanos, que apresentam menor probabilidade de elicitar imunogenicidade. O objetivo deste trabalho consistiu em obter AcMos humanos antitetânicos através da separação de linfócitos B produtores de anticorpos específicos utilizando o antígeno ou de plasmablastos. As células foram coletadas de doadores após vacinação e separadas por equipamento de cell sorter. As regiões variáveis dos anticorpos foram amplificadas e clonadas em vetores de expressão, que foram usados para transfectar transitoriamente células HEK293-F. O uso da toxina tetânica conjugada independentemente com dois marcadores, biotina e Alexa Fluor® 647, possibilitou a separação específica de linfócitos B produtores de AcMos antitetânicos, que foram avaliados por ELISA, western blotting e pela inibição da ligação da toxina ao gangliosídio GT1b. O ensaio in vivo mostrou proteção total dos animais contra a toxina tetânica quando três AcMos foram usados em conjunto. / Monoclonal antibodies (mAbs) for therapeutic use correspond to a major area of the biopharmaceutical industry, especially human mAbs that are less prone to elicit immunogenicity. The objective of this work was to obtain anti-tetanus human mAbs through separation of memory B lymphocytes producing specific antibodies stained with the antigen or plasmablasts. Cells were collected from peripheral blood of donors after vaccination and separated through cell sorting. The variable regions of the antibodies were amplified and cloned in expression vectors for transient transfection of HEK293-F cells. The staining with the tetanus toxin labeled independently with two markers, biotin and Alexa Fluor® 647 allowed the separation of specific B lymphocytes producing anti-tetanus mAbs. The antibodies expressed were evaluated by ELISA, western blotting and the inhibition of the binding of the tetanus toxin to the ganglioside GT1b. The in vivo neutralization assay showed that a pool of three different mAbs were able to protect mice against the tetanus toxin.
6

Obtenção de anticorpos monoclonais humanos antitetânicos. / Anti-tetanus human monoclonal antibodies.

Eduardo Aliprandini 12 August 2015 (has links)
Anticorpos monoclonais (AcMos) para uso terapêutico correspondem a uma área importante na indústria de biofármacos, em especial os AcMos humanos, que apresentam menor probabilidade de elicitar imunogenicidade. O objetivo deste trabalho consistiu em obter AcMos humanos antitetânicos através da separação de linfócitos B produtores de anticorpos específicos utilizando o antígeno ou de plasmablastos. As células foram coletadas de doadores após vacinação e separadas por equipamento de cell sorter. As regiões variáveis dos anticorpos foram amplificadas e clonadas em vetores de expressão, que foram usados para transfectar transitoriamente células HEK293-F. O uso da toxina tetânica conjugada independentemente com dois marcadores, biotina e Alexa Fluor® 647, possibilitou a separação específica de linfócitos B produtores de AcMos antitetânicos, que foram avaliados por ELISA, western blotting e pela inibição da ligação da toxina ao gangliosídio GT1b. O ensaio in vivo mostrou proteção total dos animais contra a toxina tetânica quando três AcMos foram usados em conjunto. / Monoclonal antibodies (mAbs) for therapeutic use correspond to a major area of the biopharmaceutical industry, especially human mAbs that are less prone to elicit immunogenicity. The objective of this work was to obtain anti-tetanus human mAbs through separation of memory B lymphocytes producing specific antibodies stained with the antigen or plasmablasts. Cells were collected from peripheral blood of donors after vaccination and separated through cell sorting. The variable regions of the antibodies were amplified and cloned in expression vectors for transient transfection of HEK293-F cells. The staining with the tetanus toxin labeled independently with two markers, biotin and Alexa Fluor® 647 allowed the separation of specific B lymphocytes producing anti-tetanus mAbs. The antibodies expressed were evaluated by ELISA, western blotting and the inhibition of the binding of the tetanus toxin to the ganglioside GT1b. The in vivo neutralization assay showed that a pool of three different mAbs were able to protect mice against the tetanus toxin.
7

Die vollständige Entschlüsselung der Genomsequenz des Tetanus-Erregers <i>Clostridium tetani</i> und die Analyse seines genetischen Potentials / The complete genome sequence of the causative agent of tetanus disease, <i>Clostridium tetani</i>, and the analysis of its genes

Brüggemann, Holger 30 January 2003 (has links)
No description available.
8

Neurotoxins

Kostrzewa, Richard M. 01 January 2016 (has links)
The era of selective neurotoxins arose predominately in the 1960s with the discovery of the norepinephrine (NE) isomer 6-hydroxydopamine (6-OHDA), which selectively destroyed noradrenergic sympathetic nerves in rats. A series of similarly selective neurotoxins were later discovered, having high affinity for the transporter site on nerves and thus being accumulated and able to disrupt vital intraneuronal processes, to lead to cell death. The Trojan Horse botulinum neurotoxins (BoNT) and tetanus toxin bind to glycoproteins on the neuronal plasma membrane, then these stealth neurotoxins are taken inside respective cholinergic or glycinergic nerves, producing months-long functional inactivation but without overtly destroying those nerves. The mitochondrial complex I inhibitor rotenone, while lacking total specificity, still destroys dopaminergic nerves with some selectivity; and importantly, results in the neural accumulation of synuclein-to model Parkinson’s disease (PD) in animals. Other neurotoxins target specific subtypes of glutamate receptors and produce excitotoxicity in nerves with that receptor population. The dopamine D2 receptor agonist quinpirole, termed a selective neurotoxin, produces a behavioral state replicating some of the notable features of schizophrenia, but without overtly destroying nerves. These processes, mechanisms or treatment-outcomes account for the means by which neurotoxins are classified as such, and represent some of the means by which neurotoxins as a group are able to destroy or functionally inactivate nerves; or replicate an altered neurological state. Selective neurotoxins have proven to be important in gaining insight into biochemical processes and mechanisms responsible for survival or demise of a nerve. Selective neurotoxins are useful also for animal modeling of human neural disorders such as PD, Alzheimer disease, attention-deficit hyperactivity disorder (ADHD), Lesch-Nyhan disease, tardive dyskinesia, schizophrenia and others. The importance of neurotoxins in neuroscience will continue to be ever more important as even newer neurotoxins are discovered.

Page generated in 0.0447 seconds